Literature DB >> 35569989

A Case of Bing-Neel Syndrome Successfully Treated with Tirabrutinib.

Takashi Oyama1, Kazuki Taoka1, Akira Chiba1, Kensuke Matsuda1, Hiroaki Maki1, Yosuke Masamoto1, Mineo Kurokawa1,2.   

Abstract

Bing-Neel syndrome (BNS) is a rare central nervous system manifestation of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia (LPL/WM). We herein report a 62-year-old man with LPL/WM after multiple chemotherapies. He had weakness of lower extremities and elevated serum IgM levels. A bone marrow examination showed lymphoplasmacytic cells infiltration. Contrast-enhanced magnetic resonance imaging suggested enhancing lesions in the cauda equina roots. He was diagnosed with BNS and started on treatment with tirabrutinib 480 mg daily. Within three months, he showed clinical and radiologic improvement. Tirabrutinib may have utility as an effective treatment for BNS.

Entities:  

Keywords:  Bing-Neel syndrome; Lymphoplasmacytic lymphoma; Waldenström macroglobulinemia; ibrutinib; tirabrutinib

Year:  2022        PMID: 35569989     DOI: 10.2169/internalmedicine.9545-22

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  1 in total

1.  Bing-Neel Syndrome, a Rare Presentation of Waldenström Macroglobulinemia-A Multicenter Report by the Polish Lymphoma Research Group.

Authors:  Joanna Drozd-Sokołowska; Anna Waszczuk-Gajda; Magdalena Witkowska; Elżbieta Sienkiewicz; Anna Kopińska; Agnieszka Kołkowska-Leśniak; Joanna Barankiewicz; Monika Długosz-Danecka; Piotr Smolewski; Grzegorz Helbig; Ewa Lech-Marańda; Wojciech Jurczak; Przemysław Biecek; Sebastian Giebel; Wiesław Wiktor-Jędrzejczak; Grzegorz Basak
Journal:  J Clin Med       Date:  2022-07-30       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.